Kinapse Blog
Read our latest insights into the Life Sciences industry.
The Regulatory Times – March 2019
Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read March's edition from Kinapse.
Brexit is Approaching: What are the Implications for the EU QPPV?
With the UK set to leave the EU in the near future, Kinapse examines the potential implications for the EU QPPV
The Regulatory Times February 2019
Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read February's edition from Kinapse.
Kinapse Joins the Pistoia Alliance
Kinapse become the latest company to join the Pistoia Alliance, a global, not-for-profit alliance of life science companies, vendors, publishers and more.
Kinapse Contribute to Guideline ICH Q12 Comments
Kinapse offers comments on ICH guideline Q12. Follow the link to read comments on this guideline by Kinapse and other life sciences organisations.
The Regulatory Times December 2018
Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read December's edition from Kinapse.
3 key takeaways from the Patient Centred Pharma Forum 2018
The forum of patient representatives and industry leaders discussed three key areas of evolution in patient centricity. Follow the link to read our summary.
The Regulatory Times October 2018
Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read October's edition from Kinapse.
Getting to the Centre of RIM: Technology-Driven Regulatory Operations
Learn how Regulatory Operations can introduce intelligent solutions to advance capabilities and operate more efficiently on a global scale
The Regulatory Times September 2018
Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read September's edition from Kinapse.
Syneos Health™ acquires Kinapse to further enhance end-to-end capabilities
Addition of Market Leading Advisory and Operational Solutions Provider Increases High-Value Offerings and Expands Operational Scale in Key Growth Markets.
GDPR: what are organisations doing post-May 25th?
Since the GDPR enforcement date, what barriers to compliance are organisations continuing to face, and how are they addressing this?
Transparency and Public Interest: Striking a Balance
Learn why requirements for plain-language summaries of clinical studies, aimed at a broad, non-technical audience, could create new risks for sponsors.
The Regulatory Times August 2018
Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read August's edition from Kinapse.
The applications of blockchain in clinical trials
Trust is a significant issue in Pharma. Blockchain could solve this problem and more in clinical trials, increasing transparency and saving time.
Improving patient perceptions of clinical studies
Learn how leading organisations are engaging patients from trial design to study close-out to create a holistic framework for improving patient experience.